Maarso 2023: Cutubka koowaad ee xusuusta Sam Neill waxay naxdin weyn u noqon doontaa qof aan aqoon hore u lahayn. Waxay ku bilaabataa qosol ku filan: dun weyn oo ku saabsan gabadhiisa Elena oo wax laga weyddiiyey jowhar aabaheed.
Soo koobid Kooban: Daraasad ku saabsan daawaynta unugyada APRIL CAR-T ee bukaannada qaba BCMA/TACI ee soo laabashada togan iyo/ama soo noqnoqota ee myeloma badan oo faahfaahsan Faahfaahin: Tani waa hal gacan, sumad furan, si..
Juun 2022: FDA waxay ansixisay dawada azacitidine (Vidaza, Celgene Corp.) ee carruurta dhawaan la ogaaday ee myelomonocytic leukemia (JMML) .
Maarso 2022: Kadib afar ama in ka badan oo daawaynta ka hor ah, oo ay ku jiraan proteasome inhibitor (PI), wakiilka immunomodulatory (IMiD), iyo anti-CD38 monoclonal antibody, Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay ciltacabtagene au.
March 2022: Jaamacadda Texas MD Anderson Cancer Center cilmi-baarayaasha ayaa ogaaday in axi-cel, autologous anti-CD19 chimeric antigen reseptor (daaweynta CAR T-cell), ay tahay daawaynta safka kowaad ee badbaado leh.
Maarso 2022: Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay rituximab (Rituxan, Genentech, Inc.) iyada oo lala kaashanayo kiimoterabiga loogu talagalay CD20-positive diffuse big B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
Maarso 2022: Daratumumab + hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) iyo carfilzomib (Kyprolis, Amgen, Inc.) iyo dexamethasone waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee bukaanka qaangaarka ah ee soo noqnoqda.
Dec 2020: Cilmi-baarayaasha Xarunta Kansarka ee Jaamacadda Texas MD Anderson waxay ogaadeen in axi-cel, oo ah autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, ay tahay daawaynta safka koowaad ee badbaado leh oo waxtar leh bukaannada qaba ...
Noofambar 2021: Asciminib (Scemblix, Novartis AG) waxaa siisay ogolaansho degdeg ah Maamulka Cuntada iyo Dawooyinka ee bukaanada qaba Philadelphia chromosome-positive chronic myeloid leukemia (Ph + CML) ee marxaladda dabadheeraatay (CP) kuwaas oo lahaa pr..
Oktoobar 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) waxaa u ansixiyay Maamulka Cuntada iyo Dawooyinka ee bukaanada qaangaarka ah ee soo noqnoqday ama dib u celinaya unugyada B-unugyada limfoblastic leukemia (ALL). Gudaha